#antibodies

Prior to the rollout of the vaccine, pregnant Black and Latino people were most affected by COVID-19.

Inequality, structural racism and unemployment rates all play a role in the likelihood of preterm births.

Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.

Cancer patients undergoing treatment and those with suppressed immune systems eye the future—and the COVID pandemic’s wane—warily.

Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.

The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.

Evidence is growing that contracting SARS-CoV-2 is generally as effective as vaccination at preventing COVID-19.

People who received the Moderna COVID-19 vaccine had strong immune memory of SARS-CoV-2 six months after vaccination.

What protects most children from becoming seriously ill? And why does that protection sometimes fail?

About half of people hospitalized with COVID-19 had antibodies that could mistakenly attack the body’s own proteins and tissues.

Early treatment is linked to a smaller viral reservoir, but blocking IL-10 and PD-1 might control the virus in those with chronic infection.

Based on surveys conducted in 2015 and 2018, the number appears to have nearly tripled in San Francisco.

Scientific evidence appears to show that vaccine-induced immunity is stronger than what the body generates after natural infection.

The CDC recommends that everyone ages 13 to 64 get a routine HIV test at least once.

Bamlanivimab and etesevimab may be given to people with mild to moderate COVID-19 who are at high risk for progression to severe disease.

More than 95% of people who recovered from COVID-19 had durable immune system memory up to eight months after infection.